
Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to …

Celgene president and chief operating officer Mike Alles has been promoted to the top job after an executive restructure at …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

